PL3937902T3 - Farmaceutyczna forma dawkowania do nakładania na błony śluzowe i sposób jej tworzenia - Google Patents

Farmaceutyczna forma dawkowania do nakładania na błony śluzowe i sposób jej tworzenia

Info

Publication number
PL3937902T3
PL3937902T3 PL20713215.0T PL20713215T PL3937902T3 PL 3937902 T3 PL3937902 T3 PL 3937902T3 PL 20713215 T PL20713215 T PL 20713215T PL 3937902 T3 PL3937902 T3 PL 3937902T3
Authority
PL
Poland
Prior art keywords
mucals
preparation
application
dosage form
pharmaceutical dosage
Prior art date
Application number
PL20713215.0T
Other languages
English (en)
Inventor
Julius KRAUSE
Original Assignee
Esocap Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Esocap Ag filed Critical Esocap Ag
Publication of PL3937902T3 publication Critical patent/PL3937902T3/pl

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0031Rectum, anus
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61JCONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
    • A61J3/00Devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms
    • A61J3/07Devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms into the form of capsules or similar small containers for oral use
    • A61J3/071Devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms into the form of capsules or similar small containers for oral use into the form of telescopically engaged two-piece capsules
    • A61J3/074Filling capsules; Related operations
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61JCONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
    • A61J3/00Devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms
    • A61J3/07Devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms into the form of capsules or similar small containers for oral use
    • A61J3/071Devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms into the form of capsules or similar small containers for oral use into the form of telescopically engaged two-piece capsules
    • A61J3/077Manufacturing capsule shells
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61JCONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
    • A61J7/00Devices for administering medicines orally, e.g. spoons; Pill counting devices; Arrangements for time indication or reminder for taking medicine
    • A61J7/0015Devices specially adapted for taking medicines
    • A61J7/0061Swallow helping devices, e.g. tongue shields
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19Carboxylic acids, e.g. valproic acid
    • A61K31/195Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/196Carboxylic acids, e.g. valproic acid having an amino group the amino group being directly attached to a ring, e.g. anthranilic acid, mefenamic acid, diclofenac, chlorambucil
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/58Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/38Cellulose; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0034Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0053Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/006Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4808Preparations in capsules, e.g. of gelatin, of chocolate characterised by the form of the capsule or the structure of the filling; Capsules containing small tablets; Capsules with outer layer for immediate drug release
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841Filling excipients; Inactive ingredients
    • A61K9/4866Organic macromolecular compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/70Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7007Drug-containing films, membranes or sheets
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M31/00Devices for introducing or retaining media, e.g. remedies, in cavities of the body
    • A61M31/002Devices for releasing a drug at a continuous and controlled rate for a prolonged period of time
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M31/00Devices for introducing or retaining media, e.g. remedies, in cavities of the body
    • A61M31/007Injectors for solid bodies, e.g. suppositories
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2210/00Anatomical parts of the body
    • A61M2210/06Head
    • A61M2210/0625Mouth
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2210/00Anatomical parts of the body
    • A61M2210/10Trunk
    • A61M2210/1042Alimentary tract
    • A61M2210/1067Anus
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2210/00Anatomical parts of the body
    • A61M2210/14Female reproductive, genital organs
    • A61M2210/1475Vagina

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Inorganic Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Anesthesiology (AREA)
  • Physiology (AREA)
  • Nutrition Science (AREA)
  • Urology & Nephrology (AREA)
  • Reproductive Health (AREA)
  • Gynecology & Obstetrics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Manufacturing & Machinery (AREA)
  • Medicinal Preparation (AREA)
  • Medical Preparation Storing Or Oral Administration Devices (AREA)
PL20713215.0T 2019-03-14 2020-03-13 Farmaceutyczna forma dawkowania do nakładania na błony śluzowe i sposób jej tworzenia PL3937902T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP19162908 2019-03-14
EP19192961 2019-08-21
PCT/EP2020/056934 WO2020183005A1 (en) 2019-03-14 2020-03-13 Pharmaceutical dosage form for application to mucous membranes and methods for producing same

Publications (1)

Publication Number Publication Date
PL3937902T3 true PL3937902T3 (pl) 2024-04-15

Family

ID=69941338

Family Applications (1)

Application Number Title Priority Date Filing Date
PL20713215.0T PL3937902T3 (pl) 2019-03-14 2020-03-13 Farmaceutyczna forma dawkowania do nakładania na błony śluzowe i sposób jej tworzenia

Country Status (20)

Country Link
US (1) US12403098B2 (pl)
EP (1) EP3937902B1 (pl)
JP (1) JP7396557B2 (pl)
KR (1) KR102912999B1 (pl)
CN (2) CN113727698B (pl)
AU (1) AU2020234029B2 (pl)
BR (1) BR112021017069A2 (pl)
DK (1) DK3937902T3 (pl)
ES (1) ES2970329T3 (pl)
FI (1) FI3937902T3 (pl)
HU (1) HUE064867T2 (pl)
IL (1) IL285899B2 (pl)
MX (1) MX2021010972A (pl)
PL (1) PL3937902T3 (pl)
SG (1) SG11202109123XA (pl)
SI (1) SI3937902T1 (pl)
TW (1) TWI829888B (pl)
UY (1) UY38610A (pl)
WO (1) WO2020183005A1 (pl)
ZA (1) ZA202105976B (pl)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102021120937A1 (de) * 2021-08-11 2023-02-16 Lts Lohmann Therapie-Systeme Ag. Oraler Dünnfilm
UY39782A (es) 2021-05-21 2023-01-31 Esocap Ag Dispositivo de cápsula con una abertura formada por una parte de pared de una de las dos cubiertas d
HUE073059T2 (hu) * 2021-05-21 2025-12-28 Esocap Ag Kapszulaeszköz két félkapszula-héj átfedésével kialakított nyílással
TW202412745A (zh) 2022-06-07 2024-04-01 瑞士商意梭凱普公司 應用於食道黏膜的包含抗發炎劑或抗發炎劑之鹽的藥物傳遞系統
TW202412754A (zh) 2022-06-07 2024-04-01 瑞士商意梭凱普公司 應用於食道黏膜的包含逆流抑制劑的藥物傳遞系統
TW202412744A (zh) 2022-06-07 2024-04-01 瑞士商意梭凱普公司 包括應用在食道黏膜之藥劑的藥物遞送系統及其應用
JP2025541251A (ja) * 2022-12-13 2025-12-18 ヴェリリー ライフ サイエンシズ エルエルシー インビボ環境での自己配向能を有する摂取可能なデバイス
DE102023119018A1 (de) 2023-07-19 2025-01-23 Lts Lohmann Therapie-Systeme Ag. Verfahren und Vorrichtung zur Herstellung eines Applikationssystems für ein schluckbares Objekt, Applikationssystem und Trinkbechersystem zur Applikation eines schluckbaren Objekts

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1151823A (en) 1982-09-02 1983-08-16 Leonard Mackie Hard shell gelatin capsule dipping apparatus and method
GB9004702D0 (en) 1990-03-02 1990-04-25 Polysystems Limited Dispensing device
AU7991191A (en) 1990-05-23 1991-12-10 Southwest Research Institute Filament system for delivering a medicament and method
AU650113B2 (en) 1991-04-05 1994-06-09 Eli Lilly And Company Sustained release capsule and formulations
US6183466B1 (en) 1998-08-21 2001-02-06 Alza Corporation Dosage form comprising a capsule
AUPQ254199A0 (en) 1999-08-31 1999-09-23 University Of Western Australia, The Methods and devices for obtaining samples from hollow viscera
US6585997B2 (en) 2001-08-16 2003-07-01 Access Pharmaceuticals, Inc. Mucoadhesive erodible drug delivery device for controlled administration of pharmaceuticals and other active compounds
WO2005039499A2 (en) * 2003-10-24 2005-05-06 Adhesives Research, Inc. Rapidly disintegrating film
EP2997953B1 (en) 2006-01-18 2018-12-26 Intec Pharma Ltd. Delivery device for oral intake of an agent
PL2349222T3 (pl) * 2008-09-10 2017-08-31 Sandoz Ag Kapsułka z rozpuszczalnym elementem blokującym
EP2432437A4 (en) 2009-05-21 2012-12-19 Bionex Pharmaceuticals Llc TWO- AND ONE-LAYER DOSAGE FORMS
EP2490677A2 (en) * 2009-10-19 2012-08-29 Intec Pharma Ltd. Novel gastroretentive dosage forms of poorly soluble drugs
EP3653223B1 (en) * 2011-06-29 2021-08-25 Rani Therapeutics, LLC Device for the oral delivery of therapeutic compounds
US20140335153A1 (en) * 2013-05-09 2014-11-13 Cure Pharmaceutical Corporation Thin film with high load of active ingredient
CN105916541A (zh) 2013-09-26 2016-08-31 医学量度个性化药物输送有限公司 具有阈值释放装置的传送胶囊
DE102014119576A1 (de) * 2014-12-23 2016-06-23 Ernst-Moritz-Arndt-Universität Greifswald Pharmazeutische Arzneimittelform zur Applikation auf Schleimhäuten

Also Published As

Publication number Publication date
NZ779304A (en) 2025-02-28
DK3937902T3 (da) 2024-01-29
US20220151939A1 (en) 2022-05-19
AU2020234029B2 (en) 2025-01-30
IL285899A (en) 2021-10-31
HUE064867T2 (hu) 2024-04-28
CN113727698A (zh) 2021-11-30
MX2021010972A (es) 2021-10-13
EP3937902A1 (en) 2022-01-19
KR20210142660A (ko) 2021-11-25
TWI829888B (zh) 2024-01-21
US12403098B2 (en) 2025-09-02
SI3937902T1 (sl) 2024-03-29
ZA202105976B (en) 2023-04-26
AU2020234029A1 (en) 2021-09-16
KR102912999B1 (ko) 2026-01-15
CN119214987A (zh) 2024-12-31
CA3131148A1 (en) 2020-09-17
ES2970329T3 (es) 2024-05-28
EP3937902B1 (en) 2023-11-01
IL285899B1 (en) 2024-09-01
JP7396557B2 (ja) 2023-12-12
WO2020183005A1 (en) 2020-09-17
JP2022524109A (ja) 2022-04-27
FI3937902T3 (fi) 2024-01-30
IL285899B2 (en) 2025-01-01
TW202103685A (zh) 2021-02-01
BR112021017069A2 (pt) 2021-11-09
SG11202109123XA (en) 2021-09-29
UY38610A (es) 2020-08-31
CN113727698B (zh) 2024-08-30

Similar Documents

Publication Publication Date Title
PL3937902T3 (pl) Farmaceutyczna forma dawkowania do nakładania na błony śluzowe i sposób jej tworzenia
IL290364A (en) Methods and apparatuses for manufacturing for removing material from a therapeutic composition
IL283852A (en) Amyloid precursor protein (app) rnai agent compositions and methods of use thereof
MA53388A (fr) Inhibiteurs d'inflammasome nlrp3
PL3717471T3 (pl) Nowe związki i zawierające je kompozycje farmaceutyczne do leczenia chorób
PT4031110T (pt) Formas farmacêuticas de inibidores de tyk2
HRP20251694T1 (hr) Optimizirano doziranje diaminofenotiazina u populacijama
IL280937A (en) Vitamin d pediatric dosage forms, methods of making and using
LT3681483T (lt) Terapinio baltymo farmacinės formos liofilizavimo būdas
PL3502105T3 (pl) Postać polimorficzna związku stanowiącego inhibitor kinazy, zawierająca ją kompozycja farmaceutyczna oraz sposób jej wytwarzania i jej zastosowanie
IL282813A (en) Antibody formulation
IL281976A (en) Anti-fgfr2 antibody formulations
IL285546A (en) Compounds and methods for reducing kcnt1 expression
PL3300724T3 (pl) Cząstka zawierająca co najmniej substancję lotną i sposób jej wytwarzania
DK3769765T3 (da) Farmaceutisk sammensætning indeholdende natriumalkylsulfat
IL279622A (en) Pharmaceutical formulations of masked antibodies
PL2956011T3 (pl) Kompozycja do żucia do podawania doustnego i sposób jej wytwarzania
IL285765A (en) Therapeutic uses of dulaglutide
PL3349778T3 (pl) Związek farmaceutyczny agonisty receptora czynnika wzrostu i inhibitora białka adhezyjnego do przekształcania komórki nowotworowej w komórkę nienowotworową i jego zastosowanie
PL3426230T3 (pl) Stałe postacie dawkowania wigabatryny
EP3795166A4 (en) PHARMACEUTICAL COMPOSITION OF KOR RECEPTOR AGONIST
IL283656A (en) New crystalline forms of a mcl-1 inhibitor, a process for their preparation and pharmaceutical compositions containing them
PL394169A1 (pl) Kompozycja farmaceutyczna metanosulfonianu imatinibu do napełniania jednostkowych postaci dawkowania oraz sposób jej wytwarzania
ZA202110948B (en) Pharmaceutical dosage forms and methods for their production
IL283281A (en) Formulation of contrast media and process of preparation thereof